nodes	percent_of_prediction	percent_of_DWPC	metapath
Betaxolol—hypertension—focal segmental glomerulosclerosis	0.911	1	CtDrD
Betaxolol—Fibroadenosis of breast—Cyclosporine—focal segmental glomerulosclerosis	0.00664	0.0748	CcSEcCtD
Betaxolol—Fibroadenoma of breast—Cyclosporine—focal segmental glomerulosclerosis	0.00619	0.0698	CcSEcCtD
Betaxolol—Sensation of foreign body—Cyclosporine—focal segmental glomerulosclerosis	0.00276	0.0311	CcSEcCtD
Betaxolol—Peripheral ischaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00246	0.0278	CcSEcCtD
Betaxolol—Hypertrichosis—Cyclosporine—focal segmental glomerulosclerosis	0.00236	0.0266	CcSEcCtD
Betaxolol—Thrombocytopenic purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00192	0.0216	CcSEcCtD
Betaxolol—Cerebration impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00153	0.0172	CcSEcCtD
Betaxolol—Psoriasis—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.0161	CcSEcCtD
Betaxolol—Menstrual disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00132	0.0149	CcSEcCtD
Betaxolol—Thrombosis—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.0143	CcSEcCtD
Betaxolol—Hyperlipidaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00125	0.0141	CcSEcCtD
Betaxolol—Rigors—Cyclosporine—focal segmental glomerulosclerosis	0.0011	0.0124	CcSEcCtD
Betaxolol—Disturbance in attention—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.0117	CcSEcCtD
Betaxolol—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.0116	CcSEcCtD
Betaxolol—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.000988	0.0111	CcSEcCtD
Betaxolol—Glossitis—Cyclosporine—focal segmental glomerulosclerosis	0.000975	0.011	CcSEcCtD
Betaxolol—Lacrimation increased—Cyclosporine—focal segmental glomerulosclerosis	0.000975	0.011	CcSEcCtD
Betaxolol—Hyperuricaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000968	0.0109	CcSEcCtD
Betaxolol—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.000962	0.0108	CcSEcCtD
Betaxolol—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.000943	0.0106	CcSEcCtD
Betaxolol—Blood uric acid increased—Cyclosporine—focal segmental glomerulosclerosis	0.000915	0.0103	CcSEcCtD
Betaxolol—Hyperkalaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000882	0.00995	CcSEcCtD
Betaxolol—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.000867	0.00978	CcSEcCtD
Betaxolol—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.000843	0.00951	CcSEcCtD
Betaxolol—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.000825	0.00931	CcSEcCtD
Betaxolol—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.000783	0.00883	CcSEcCtD
Betaxolol—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.000779	0.00879	CcSEcCtD
Betaxolol—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000764	0.00862	CcSEcCtD
Betaxolol—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.000749	0.00845	CcSEcCtD
Betaxolol—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.000729	0.00822	CcSEcCtD
Betaxolol—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.000729	0.00822	CcSEcCtD
Betaxolol—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.000729	0.00822	CcSEcCtD
Betaxolol—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.000725	0.00818	CcSEcCtD
Betaxolol—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.000722	0.00814	CcSEcCtD
Betaxolol—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.000709	0.008	CcSEcCtD
Betaxolol—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.000703	0.00793	CcSEcCtD
Betaxolol—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000694	0.00783	CcSEcCtD
Betaxolol—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.000685	0.00773	CcSEcCtD
Betaxolol—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.000676	0.00763	CcSEcCtD
Betaxolol—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.000671	0.00757	CcSEcCtD
Betaxolol—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.000668	0.00753	CcSEcCtD
Betaxolol—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000668	0.00753	CcSEcCtD
Betaxolol—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.000665	0.0075	CcSEcCtD
Betaxolol—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.000652	0.00735	CcSEcCtD
Betaxolol—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.000647	0.00729	CcSEcCtD
Betaxolol—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.000642	0.00724	CcSEcCtD
Betaxolol—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.000618	0.00697	CcSEcCtD
Betaxolol—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000589	0.00664	CcSEcCtD
Betaxolol—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.000587	0.00662	CcSEcCtD
Betaxolol—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.000563	0.00635	CcSEcCtD
Betaxolol—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.000554	0.00625	CcSEcCtD
Betaxolol—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.000542	0.00611	CcSEcCtD
Betaxolol—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.000527	0.00594	CcSEcCtD
Betaxolol—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000524	0.00591	CcSEcCtD
Betaxolol—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.000513	0.00578	CcSEcCtD
Betaxolol—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00051	0.00575	CcSEcCtD
Betaxolol—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000508	0.00573	CcSEcCtD
Betaxolol—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.000505	0.0057	CcSEcCtD
Betaxolol—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.000502	0.00567	CcSEcCtD
Betaxolol—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.000502	0.00567	CcSEcCtD
Betaxolol—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.000501	0.00565	CcSEcCtD
Betaxolol—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.000495	0.00559	CcSEcCtD
Betaxolol—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.000492	0.00555	CcSEcCtD
Betaxolol—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.000492	0.00555	CcSEcCtD
Betaxolol—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00049	0.00552	CcSEcCtD
Betaxolol—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.000488	0.00551	CcSEcCtD
Betaxolol—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.000474	0.00534	CcSEcCtD
Betaxolol—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.000471	0.00532	CcSEcCtD
Betaxolol—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.000452	0.0051	CcSEcCtD
Betaxolol—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000449	0.00506	CcSEcCtD
Betaxolol—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.000448	0.00505	CcSEcCtD
Betaxolol—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.000435	0.0049	CcSEcCtD
Betaxolol—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00042	0.00474	CcSEcCtD
Betaxolol—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.000419	0.00472	CcSEcCtD
Betaxolol—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000409	0.00461	CcSEcCtD
Betaxolol—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000406	0.00458	CcSEcCtD
Betaxolol—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.000405	0.00456	CcSEcCtD
Betaxolol—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.000403	0.00454	CcSEcCtD
Betaxolol—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.000399	0.00449	CcSEcCtD
Betaxolol—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000395	0.00446	CcSEcCtD
Betaxolol—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.000393	0.00443	CcSEcCtD
Betaxolol—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.000385	0.00435	CcSEcCtD
Betaxolol—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000384	0.00434	CcSEcCtD
Betaxolol—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.000381	0.0043	CcSEcCtD
Betaxolol—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.000377	0.00426	CcSEcCtD
Betaxolol—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00037	0.00417	CcSEcCtD
Betaxolol—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.000368	0.00415	CcSEcCtD
Betaxolol—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000364	0.00411	CcSEcCtD
Betaxolol—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000363	0.00409	CcSEcCtD
Betaxolol—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000354	0.00399	CcSEcCtD
Betaxolol—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.000353	0.00398	CcSEcCtD
Betaxolol—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000343	0.00386	CcSEcCtD
Betaxolol—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000334	0.00377	CcSEcCtD
Betaxolol—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000334	0.00377	CcSEcCtD
Betaxolol—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000334	0.00377	CcSEcCtD
Betaxolol—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000333	0.00376	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000332	0.00374	CcSEcCtD
Betaxolol—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00033	0.00372	CcSEcCtD
Betaxolol—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000327	0.00369	CcSEcCtD
Betaxolol—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000323	0.00364	CcSEcCtD
Betaxolol—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00032	0.00361	CcSEcCtD
Betaxolol—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000318	0.00359	CcSEcCtD
Betaxolol—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000314	0.00354	CcSEcCtD
Betaxolol—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000314	0.00354	CcSEcCtD
Betaxolol—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000311	0.00351	CcSEcCtD
Betaxolol—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00031	0.00349	CcSEcCtD
Betaxolol—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000305	0.00344	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000292	0.00329	CcSEcCtD
Betaxolol—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00029	0.00327	CcSEcCtD
Betaxolol—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000288	0.00324	CcSEcCtD
Betaxolol—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000286	0.00322	CcSEcCtD
Betaxolol—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000282	0.00318	CcSEcCtD
Betaxolol—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000279	0.00314	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000277	0.00312	CcSEcCtD
Betaxolol—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000276	0.00312	CcSEcCtD
Betaxolol—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000274	0.00309	CcSEcCtD
Betaxolol—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000274	0.00309	CcSEcCtD
Betaxolol—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000264	0.00298	CcSEcCtD
Betaxolol—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000255	0.00287	CcSEcCtD
Betaxolol—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000253	0.00286	CcSEcCtD
Betaxolol—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000236	0.00266	CcSEcCtD
Betaxolol—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00023	0.00259	CcSEcCtD
Betaxolol—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000227	0.00256	CcSEcCtD
Betaxolol—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000219	0.00247	CcSEcCtD
Betaxolol—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000212	0.00239	CcSEcCtD
Betaxolol—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000204	0.0023	CcSEcCtD
Betaxolol—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000202	0.00228	CcSEcCtD
Betaxolol—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000202	0.00228	CcSEcCtD
Betaxolol—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000201	0.00226	CcSEcCtD
Betaxolol—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00019	0.00215	CcSEcCtD
